| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.8M | -21.9% |
| Cost of Revenue | $6.2M | -20.2% |
| Gross Profit | $1.6M | -27.7% |
| R&D Expense | $1.8M | — |
| SG&A Expense | $1.7M | -28.8% |
| Operating Income | -$14.0M | -110.1% |
| Interest Expense | $4.8M | +80.6% |
| Pre-tax Income | -$21.7M | -431.1% |
| Income Tax | $0 | — |
| Net Income | -$21.7M | -431.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88K | -83.0% |
| Accounts Receivable | $194K | +90.2% |
| Current Assets | $985K | +32.7% |
| Total Assets | $1.1M | -90.1% |
| Current Liabilities | $31.9M | -4.7% |
| Long-term Debt | $144K | -33.9% |
| Total Liabilities | $34.0M | -7.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$226K | +77.2% |
| Investing Cash Flow | -$23K | -107.0% |
| Financing Cash Flow | -$181K | -115.4% |
| Stockholders' Equity |
| -$91.2M |
| -192.8% |